FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Hikma Pharmaceuticals Alendronate Sodium Oral Solution Recall

Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bo…

Hikma Pharmaceuticals USA INC · Columbus, OH

Risk level
Class II
Reported by FDA
May 6, 2026
Recall ID
D-0526-2026
Check your lot numberHow we source this data

Summary

Hikma Pharmaceuticals recalled Alendronate Sodium Oral Solution starting Apr 7, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0526-2026 on May 6, 2026. Reason: This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side. Status: Ongoing.

Why it was recalled

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

Product description

Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0282-59.

Lot numbers, UPCs & expiration codes

Lot # AC2040A, Exp Date: 04/2026

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0526-2026
Classification
Class II
Status
Ongoing
Recall initiated
Apr 7, 2026
FDA report date
May 6, 2026
Quantity
4 single dose 75 ml bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Hikma Pharmaceuticals USA INC

Original FDA data

Every field from FDA enforcement report D-0526-2026, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Ongoing
Country
United States
Event ID
98744
Address
1809 Wilson Rd
Code information
Lot # AC2040A, Exp Date: 04/2026
Postal code
43228-9579
Report date
May 6, 2026
Product type
Drugs
Recall number
D-0526-2026
Classification
Class II
Recalling firm
Hikma Pharmaceuticals USA INC
Product quantity
4 single dose 75 ml bottles
Reason for recall
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0282-59.
Distribution pattern
US Nationwide.
Recall initiation date
Apr 7, 2026
Initial firm notification
Letter
Center classification date
May 8, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0526-2026, published May 6, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls